BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 10224602)

  • 21. Review on prostaglandin and oxytocin activity in preterm labor.
    Ivanisević M; Djelmis J; Buković D
    Coll Antropol; 2001 Dec; 25(2):687-94. PubMed ID: 11811300
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Oxytocin and fetal membranes in preterm labor: current concepts and clinical implication.
    Laudanski T; Pierzynski P
    Gynecol Endocrinol; 2003 Jun; 17(3):261-7. PubMed ID: 12857435
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Treatment of preterm labor with the oxytocin antagonist atosiban.
    Goodwin TM; Valenzuela G; Silver H; Hayashi R; Creasy GW; Lane R
    Am J Perinatol; 1996 Apr; 13(3):143-6. PubMed ID: 8688103
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Involvement of oxytocin and vasopressin in the pathophysiology of preterm labor and primary dysmenorrhea.
    Akerlund M
    Prog Brain Res; 2002; 139():359-65. PubMed ID: 12436949
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The pharmacokinetics of the oxytocin antagonist atosiban in pregnant women with preterm uterine contractions.
    Goodwin TM; Millar L; North L; Abrams LS; Weglein RC; Holland ML
    Am J Obstet Gynecol; 1995 Sep; 173(3 Pt 1):913-7. PubMed ID: 7573268
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Design of oxytocin antagonists, which are more selective than atosiban.
    Manning M; Stoev S; Cheng LL; Wo NC; Chan WY
    J Pept Sci; 2001 Sep; 7(9):449-65. PubMed ID: 11587184
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The effects of oxytocin and atosiban on the modulation of heart rate in pregnant women.
    Weissman A; Tobia RS; Burke YZ; Maxymovski O; Drugan A
    J Matern Fetal Neonatal Med; 2017 Feb; 30(3):329-333. PubMed ID: 27030149
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Design and synthesis of highly selective in vitro and in vivo uterine receptor antagonists of oxytocin: comparisons with Atosiban.
    Manning M; Miteva K; Pancheva S; Stoev S; Wo NC; Chan WY
    Int J Pept Protein Res; 1995; 46(3-4):244-52. PubMed ID: 8537178
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The choice of a tocolytic for the treatment of preterm labor: a critical evaluation of nifedipine versus atosiban.
    Lyndrup J; Lamont RF
    Expert Opin Investig Drugs; 2007 Jun; 16(6):843-53. PubMed ID: 17501696
    [TBL] [Abstract][Full Text] [Related]  

  • 30. FE 200 440: a selective oxytocin antagonist on the term-pregnant human uterus.
    Nilsson L; Reinheimer T; Steinwall M; Akerlund M
    BJOG; 2003 Nov; 110(11):1025-8. PubMed ID: 14592588
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Atosiban for preterm labour.
    Tsatsaris V; Carbonne B; Cabrol D
    Drugs; 2004; 64(4):375-82. PubMed ID: 14969573
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effectiveness and safety of the oxytocin antagonist atosiban versus beta-adrenergic agonists in the treatment of preterm labour.
    Nisell H; Wolff K
    BJOG; 2003 Jan; 110(1):89. PubMed ID: 12504956
    [No Abstract]   [Full Text] [Related]  

  • 33. Atosiban versus betamimetics in the treatment of preterm labour in Germany: an economic evaluation.
    Wex J; Connolly M; Rath W
    BMC Pregnancy Childbirth; 2009 Jun; 9():23. PubMed ID: 19538754
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Tocolysis with atosiban: experience in the management of premature labor before 24 weeks of pregnancy.
    Richter ON; Dorn C; van de Vondel P; Ulrich U; Schmolling J
    Arch Gynecol Obstet; 2005 Jun; 272(1):26-30. PubMed ID: 15909190
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Development and clinical experience with the new evidence-based tocolytic atosiban.
    Husslein P
    Acta Obstet Gynecol Scand; 2002 Jul; 81(7):633-41. PubMed ID: 12190838
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Inhibition of premature labor in sheep by a combined treatment of nimesulide, a prostaglandin synthase type 2 inhibitor, and atosiban, an oxytocin receptor antagonist.
    Grigsby PL; Poore KR; Hirst JJ; Jenkin G
    Am J Obstet Gynecol; 2000 Sep; 183(3):649-57. PubMed ID: 10992188
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The combination tocolytic effect of magnesium sulfate and an oxytocin receptor antagonist in myometrium from singleton and twin pregnancies.
    Arrowsmith S; Neilson J; Wray S
    Am J Obstet Gynecol; 2016 Dec; 215(6):789.e1-789.e9. PubMed ID: 27555315
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Tocolysis. Atosiban, an ocytcin-receptor antagonist].
    Schmitz T; Cabrol D
    J Gynecol Obstet Biol Reprod (Paris); 2001 May; 30(3):238-45. PubMed ID: 11397999
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Atosiban and nifedipin for the treatment of preterm labor.
    Kashanian M; Akbarian AR; Soltanzadeh M
    Int J Gynaecol Obstet; 2005 Oct; 91(1):10-4. PubMed ID: 16043178
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of oxytocin receptor and beta2-adrenoceptor blockade on myometrial oxytocin receptors in parturient rats.
    Engstrøm T; Bratholm P; Vilhardt H; Christensen NJ
    Biol Reprod; 1999 Feb; 60(2):322-9. PubMed ID: 9915997
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.